PhilipAGS. Oxygen plus pressure plus time. The etiology of bronchopulmonary dysplasia. Pediatrics1975;55:44–50.
2.
TaghizadehA, ReynoldsEOR. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am J Pathol1976;82:241–258.
3.
HarrisMC, BaumgartS, RooklinAR, FoxWW. Successful extubation of infants with respiratory distress syndrome using aminophylline. J Pediatr1983;103:303–305.
4.
HigginsRD, RichterSE, ShapiroDL, DavisJ.Nasal continuous positive airway pressure facilitates successful extubation in very low birth weight infants (abstract). Pediatr Res1990;27:209A.
5.
NorthwayWH, RosanRC, ShahinianL, CastellinoRA, GyepesMT, DurbridgeT.Radiologic and histologic investigation or pulmonary oxygen toxicity in newborn guinea pigs. Invest Radiol1969;4:148–155.
6.
NashG, BlennerhassettJB, PontoppidanH.Pulmonary lesions associated with oxygen therapy and artificial ventilation. N Engl J Med1967;276:368–374.
7.
GriffithDE, HoldenWE, MorrisJF, MinLK, KrishnamurthyGT. Effects of common therapeutic concentrations of oxygen on lung clearance of 99mTc DTPA and bronchoalveolar lavage albumin concentration. Am Rev Respir Dis1986;134:233–237.
8.
HallidayHL, DumpitFM, BradyJP. Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in bronchopulmonary dysplasia. Pediatrics1980;65:536–540.
9.
AbmanSH, WolfeRR, AccursoFJ, KoopsBL, BowmanCM, WigginsJWJr., Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics1985;75:80–84.
10.
HazinskiTA, HansenTN, SimonJA, TooleyWH. Effect of oxygen administration during sleep on skin surface oxygen and carbon dioxide tension in patients with chronic lung disease. Pediatrics1981;67:626–630.
11.
GroothuisJR, RosenbergAA, ZerleGO. Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia (abstract). Pediatr Res1986;20:227A.
12.
PinneyMA, CottonEK. Home management of bronchopulmonary dysplasia. Pediatrics1976;58:856–859.
13.
BrownER, StarkA, SosenkoS, LawsonEE, AveryME. Bronchopulmonary dysplasia: Possible relationship to pulmonary edema. J Pediatr1978;92:982–984.
14.
MayesL, PerkittE, StahlmanMT. Severe bronchopulmonary dysplasia: A retrospective review. Acta Paediatr Scand1983;72:225–229.
15.
Van MartinLJ, LevitonA, AllredEN, PaganoM, KubanKCK. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birthweight infants. J Pediatr1990;116:942–949.
16.
BancalariE, JesseMJ, GelbandH, GarciaO.Lung mechanics in congenital heart disease with increased and decreased pulmonary blood flow. J Pediatr1977;90:192–195.
17.
CottonRB, StahlmanMT, BenderHW, GrahamTP, CattertonWZ, KovarI.Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr1978;93:647–651.
18.
MerrittTA, DiSessaTC, FeldmenBH, KirkpatrickSE, GluckL, FriedmanWF. Closure of the patent ductus arteriosus with ligation and indomethacin: A consecutive experience. J Pediatr1978;93:639–646.
19.
MerrittTA, HarrisJP, RoghmannK, . Early closure of the patent ductus arteriosus in very low birth weight infants: A controlled trial. J Pediatr1981;99:281–286.
20.
ObeyesehereHI, PankhurstS, YuVYH. Pharmacological closure of ductus arteriosus in preterm infants using indomethacin. Arch Dis Child1980;55:271–276.
21.
RaoM, EidN, HerrodL, ParekhA, SteinerP.Antidiuretic hormone response in children with bronchopulmonary dysplasia during episodes of acute respiratory distress. Am J Dis Child1986;140:825–828.
22.
VelezAA, StewartJM, GewitzMH, ZeballosGA, DweckHS. Vasopressin and fluid balance in stages of respiratory distress syndrome and bronchopulmonary dysplasia (abstract). Pediatr Res1986;20:363A.
23.
MelnickG, PickoffAS, FerrerPL, PeyserJ, BancalariE, GelbandH.Normal pulmonary vascular resistance and left ventricular hypertrophy in young infants with bronchopulmonary dysplasia: An echocardiographic and pathologic study. Pediatrics1980;66:589–596.
24.
BlandRD, McMillanDD, BressackMA. Decreased pulmonary transvascular fluid filtration in awake newborn lambs after intravenous furosemide. J Clin Invest1978;62:601–609.
25.
TapiaJL, GerhardtT, GoldbergRN, Gomez-Del RioM, HehreD, BancalariE.Furosemide and lung function in neonates with chronic lung disease (abstract). Pediatr Res1983;17:336A.
NajakZD, HarrisEM, LazzaraA, PruittAW. Pulmonary effects of furosemide in preterm infants with lung disease. J Pediatr1983;102:758–763.
28.
McCannEM, LewisK, DemingDD, DonovanMJ, BradyJP. Controlled trial of furosemide therapy in infants with chronic lung disease. J Pediatr1985;106:957–962.
29.
HufnagleKG, KhanSN, PennD, CacciarelliA, WilliamsP.Renal calcifications: A complication of long-term furosemide therapy in preterm infants. Pediatrics1982;70:360–363.
30.
VenkataramanPS, HanBK, TsangRC, DaughertyCC. Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy. Am J Dis Child1983;137:1157–1161.
31.
KooWWK, GuanZP, TsangRC, LaskarzewskiP, NeumanV.Growth failure and decreased bone mineral of newborn rats with chronic furosemide therapy. Pediatr Res1986;20:74–78.
32.
SalamyA, EldredgeL, TooleyWH. Neonatal status and hearing loss in high-risk infants. J Pediatr1989;114:847–852.
33.
Gomez-Del RioM, GerhardtT, HehreD, FellerR, BancalariE.Effect of a beta-agonist nebulization on lung function in neonates with increased pulmonary resistance. Pediatr Pulmonol1986;2:287–291.
34.
KaoLC, WarburtonD, PlatzkerACG, KeensTG. Effect of isoproterenol inhalation on airway resistance in chronic bronchopulmonary dysplasia. Pediatrics1984;73:509–514.
35.
SosulskiR, AbbasiS, FoxWW. Therapeutic value of terbutaline in bronchopulmonary dysplasia (abstract). Pediatr Res1982;16:309A.
36.
RotschildA, SolimanoA, PutermanM, SharmaA, AlbersheimS, SmythJ.Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dysplasia. J Pediatr1989;115:984–991.
37.
BrundageKL, MohsiniKG, FroeseAB, FisherJT. Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia. Am Rev Respir Dis1990;142:1137–1142.
38.
Santa CruzR, LandaJ, HirschJ, SacknerMA. Tracheal mucus velocity in normal man and patients with obstructive lung disease: Effects of terbutaline. Am Rev Respir Dis1974;109:458–463.
39.
CammerP, StandbergK, PhilipsonK.Increased mucociliary transport by cholinergic stimulation. Arch Environ Health1974;29:220–224.
40.
LaurenziGA, YinS, GuarneriJJ. Adverse effect of oxygen on tracheal mucus flow. N Engl J Med1968;279:333–339.
41.
PetersonRG, SimmonsMA, RumackBH, LevineRL, BrooksJG. Pharmacology of furosemide in the premature newborn infant. J Pediatr1980;97:139–143.
42.
GerhardtT, BancalariE.Lung compliance in neonates with patent ductus arteriosus before and after surgical ligation. Biol Neonate1980;38:96–105.
43.
GerhardtT, BancalariE, HehreD, FellerR, ReifenbergL.Changes in pulmonary mechanics with growth in infants with chronic lung disease (abstract). Pediatr Res1985;19:404A.
44.
GoldmanSL, GerhardtT, SonniR, . Early prediction of chronic lung disease by pulmonary function testing. J Pediatr1983;102:613–617.
45.
KaoLC, DurandDJ, PhillipsBL, NickersonBG. Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. J Pediatr1987;111:439–444.
46.
RobertsRJ. Drug therapy in infants: Pharmacological principles and clinical experience. Philadelphia: WB Saunders Co, 1984:241–242,299.
47.
KramerLI, HultzenC.The role of steroids in early bronchopulmonary dysplasia (BPD) (abstract). Pediatr Res1978;12:564A.
48.
DonnSM, FaixRG, BanagaleRC. Dexamethasone for bronchopulmonary dysplasia (letter). Lancet1983;2:460.
49.
PomeranceJ, PuriAR. Treatment of neonatal bronchopulmonary dysplasia with steroids (abstract). Pediatr Res1980;14:649A.
50.
PomeranceJ, PuriAR. Treatment of severe neonatal bronchopulmonary dysplasia with dexamethasone (abstract). Pediatr Res1982;16:395A.
51.
SchickJB, GoetzmanBW, SmithLE, WennbergPP. Corticosteroid responsiveness in chronic lung disease of prematurity (abstract). Pediatr Res1981;15:680A.
52.
GrylackLL, ScanlonKB, ScanlonJW. Corticosteroid treatment of fourteen newborns with bronchopulmonary dysplasia (abstract). Clin Res1979;27:819A.
53.
MammelMC, GreenTP, JohnsonDE, ThompsonTR. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet1983;1:1356–1357.
54.
OhtsuN, AriagnoRL, SweeneyTE. The effects of dexamethasone on chronic pulmonary oxygen toxicity in infant mice. Pediatr Res1989;25:353–359.
55.
FrankL, LewisPL, SosenkoIRS. Dexamethasone stimulation of fetal rat lung antioxidant enzyme activity in parallel with surfactant stimulation. Pediatrics1985;75:569–574.
56.
ParilloJE, FauciAS. Mechanisms of glucocorticoid actions on immune processes. Ann Rev Pharmacol Toxicol1979;19:179–201.
57.
AveryGM, FletcherAB, KaplanM, BrudnoDS. Controlled trial of dexamethasone in respiratory-dependent infants with bronchopulmonary dysplasia. Pediatrics1985;75:106–111.
58.
CummingsJ, D'EugenioDB, GrossSJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med1989;320:1505–1510.
59.
StahlmanMT. Medical complications in premature infants: Is treatment enough?N Engl J Med1989;320:1551–1553.
60.
AlkalayAL, PomeranceJJ, PuriAR, . Hypothalamic pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone. Pediatrics1990;86:204–210.
61.
WolbachSB, HowePR. Tissue changes following deprivation of fat soluble vitamin A.J Exp Med1925;42:753–777.
62.
WongVC, BuckRG. An electron microscopic study of metaplasia of the rat tracheal epithelium in vitamin A deficiency. Lab Invest1971;24:55–66.
63.
ShenaiJ, KennedyKA, ChytilF, StahlmanMT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr1987;111:269–277.
64.
ShenaiJP, ChytilF, StahlmanMT. Liver vitamin A reserves of very low birth weight neonates. Pediatr Res1985;19:892–893.
65.
ShenaiJP, ChytilF, JhaveriA, StahlmanMT. Plasma vitamin A and retinol-binding protein in premature and term neonates. J Pediatr1981;99:302–305.